NOVASCREEN Biosciences Awarded $12.95 Million NIAID/NIH Biodefense Contract HANOVER, Md., Jan. 15, 2004 (PRIMEZONE) -- NOVASCREEN Biosciences Corporation (NovaScreen) today announced that it has been awarded a five-year, $12.95 million contract by the National Institute of...

NovaScreen Biosciences and IDBS Enter into Drug Discovery Software Collaboration HANOVER, Md., Feb. 6, 2001 (PRIMEZONE) -- NovaScreen Biosciences Corporation ("NovaScreen" or the "Company") and ID Business Solutions, Ltd. ("IDBS"), announced today that they have entered into a...

Novascreen Biosciences Names Melvin D. Booth to Board of Directors HANOVER, Md., Sept. 13, 2000 (PRIMEZONE) -- NovaScreen Biosciences Corporation (the "Company" or "NovaScreen") today announced the election of Melvin D. Booth, President and Chief Operating Officer...

Oceanix Biosciences Corporation Changes Name to NovaScreen Biosciences Corporation HANOVER, Md., Sept. 7, 2000 (PRIMEZONE)-- Oceanix Biosciences Corporation announced today that it has changed its name to NovaScreen Biosciences Corporation ("NovaScreen" or the "Company") to better...